Daxor
7 hedge funds and large institutions have $1.8M invested in Daxor in 2021 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 7 → 7 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0.74% less ownership
Funds ownership: 4.96% → 4.22% (-0.74%)
23% less capital invested
Capital invested by funds: $2.33M → $1.8M (-$530K)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$5.29K |
| 2 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
+$530 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$225K |
| 2 |
Renaissance Technologies
New York
|
-$11.7K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$8K |
| 4 |
Wells Fargo
San Francisco,
California
|
-$3.18K |
DXR Hedge Fund Activity: Q2 2021 in Review
7 of the 5,768 institutional investors tracked by Wall St. Rank reported a position in Daxor (DXR) for Q2 2021, worth a combined $1.8M — down 23% from $2.33M a quarter earlier.
Fund positioning in DXR was balanced in Q2 2021: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 3 trimmed.
The largest buyer was UBS Group, adding an estimated $5.29K. The largest seller was Sabby Management, cutting an estimated $225K.
- 7 institutional investors held Daxor (DXR) as of Q2 2021, unchanged from Q1 2021.
- Funds reported $1.8M of Daxor stock for Q2 2021, down 23% quarter-over-quarter.
- 1 fund opened new Daxor positions in Q2 2021 and 1 closed out, a net change of 0 holders.
- The largest Daxor buyer in Q2 2021 was UBS Group, an estimated $5.29K added.
- The largest Daxor seller in Q2 2021 was Sabby Management, an estimated $225K sold.
Based on aggregated 13F filings for Q2 2021.